Navigation Links
Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
Date:4/14/2008

1. Testosterone Spray Improves Sexual Satisfaction Slightly in Premenopausal Women But So Does Placebo; Editorial Says Treat Women Conventionally

A study that randomized 261 women aged 35 to 46 with self-reported low libido and low serum free testosterone levels to a group that received one of three different doses of a testosterone spray or placebo daily for 16 weeks found that all groups -- including those taking placebo--reported increased frequency of sexually satisfying events (Article, p. 569).

The difference between testosterone spray and placebo was statistically significant only for the middle dose of testosterone.

Overall, 81 percent to 86 percent of women in the active treatment groups and 70 percent of the women in the placebo group reported adverse events. The most common event in the treatment group was hair growth on the abdomen, where the testosterone was sprayed.

An editorial writer says that just because testosterone levels and womens libidos may decline as women age does not mean that lack of testosterone explains sexual dissatisfaction (Editorial, p. 620).

We do not have a fully satisfactory rationale for testosterone therapy, the writer says, and there is also a lack of long-term safety data. Rather than prescribe testosterone, the writer advises primary physicians to address womens mental health and relationship issues, sexual dysfunction in the partner and treat problems by conventional therapy, such as cognitive behavioral therapy, sex therapy, and psychotherapy.


2. Risks and Benefits of Buying Prescription Drugs from Foreign Countries

Buying imported prescription drugs is legal in some cases, but even when the drug is cheaper than a U.S. brand-name drug, it may not be a wise purchase, say authors of a paper on the international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients (Medicine and Public Issues, p. 614).

Authors posit four guidelines for patients, physicians and policymakers for importation of prescription drugs.

However, the safest way to control U.S. drug prices is by promoting consumer demand for and appropriate prescription of domestic generic drugs, they say.


3. Comprehensive Strategy Needed to Control Gonorrhea Epidemic

Incidence of Neisseria gonorrhoeae in the United States declined markedly from 1975 to 1997 and has remained relatively stable over the past decade at about 120.9 cases per 100,000 population (Perspective, p. 606).

However, rates of gonorrhea remain high in the South and among African Americans, adolescents, young adults, and men who have sex with men, and infection rates are rising. Further, the disease has serous implications for reproductive health and health costs; and treatment options have narrowed as gonorrhea has become resistant to many drugs; (currently, gonorrhea treatment options come from a single class of antimicrobials -- cephalosporins).

Authors say that in addition to developing and providing effective antimicrobial drugs, a comprehensive program to control gonorrhea must include screening people at risk for infection, surveillance for resistance, secondary screening and treatment of sex partners, and stimulating investment into research for new antimicrobials.


'/>"/>

Contact: Susan Anderson
sanderson@acponline.org
215-351-2653
American College of Physicians
Source:Eurekalert

Related medicine news :

1. NEWSWEEK: Media Lead Sheet/April 21, 2008 Issue (on newsstands Monday, April 14).
2. Annals of Internal Medicine tip sheet for April 1, 2008, issue
3. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
4. NEWSWEEK: Media Lead Sheet/March 24, 2008 Issue (on newsstands Monday, March 17)
5. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
6. VoIP-PAL.com, Inc. (Pink Sheets: VPLM.PK - News) UPDATE: Announces First Award Recipient of TalkfortheCure(TM) Dollars
7. NEWSWEEK: Media Lead Sheet/March 3, 2008 Issue (on newsstands Monday, February 25)
8. Annals of Internal Medicine tip sheet for Feb. 5, 2008, issue
9. MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling $4 Million
10. NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28)
11. NEWSWEEK: Media Lead Sheet/January 28, 2008 Issue (on newsstands Monday, January 21).
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 12, 2016 , ... The Journal of ... from 0.416 in 2013. The SJR uses data taken from the Scopus database (Elsevier ... the number of citations received by the journal over a three year period and ...
(Date:2/11/2016)... ... 2016 , ... The president released a FY 2017 budget request on Tuesday ... of the cost burden to military beneficiaries. , MOAA’s president, retired Air Force ... as including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , “We ...
(Date:2/11/2016)... ... 11, 2016 , ... Hall Integrative Health and Chiropractic, PC ... simultaneous grand openings in March. All seven practices are set to start accepting ... reversing diabetes possible? According to this 2011 CNN article it is possible: ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... women’s health, is pleased to announce the promotions of Allison Kelly to executive ... Steve Catone to executive vice president of North American capital sales, and Wendy ...
(Date:2/11/2016)... ... 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased ... Study for Plans and Purchasers.” Executives from Intel Corp. and Providence Health & ... health benefits program Connected Care, will discuss the challenges they faced (and how ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Fla. , Feb. 11, 2016 ... ) company providing high-quality specialty pharmacy care for ... announced today it has achieved full Specialty Pharmacy ... accrediting organization dedicated to promoting health care quality ... --> --> The URAC accreditation ...
(Date:2/11/2016)... , Feb. 11, 2016  M3 Biotechnology Inc., spurred by a major "team investment" by ... brother, Michael, has completed an oversubscribed Series A-Round, according to CEO Leen Kawas , PhD. ... ... ... ...
(Date:2/11/2016)... 11, 2016 SI-BONE, Inc., a medical ... iFuse Implant System, a minimally invasive surgical (MIS) ... the sacroiliac (SI) joint, announced the publication of ... MIS SI joint fusion for patients suffering from ... or SI joint disruption.  In the first article, ...
Breaking Medicine Technology: